Related references
Note: Only part of the references are listed.
Article
Multidisciplinary Sciences
Deborah Cromer et al.
Summary: The study demonstrates a strong correlation between neutralising antibody titres and vaccine effectiveness against symptomatic and severe COVID-19. Predicted neutralising antibody titres are strongly correlated with observed vaccine effectiveness, and the loss of neutralising antibodies over time and to new variants is predictive of observed vaccine protection against severe COVID-19.
NATURE COMMUNICATIONS
(2023)
Article
Immunology
Jane M. Knisely et al.
Summary: On November 7th and 8th, 2022, a virtual workshop titled "Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities" was hosted by multiple organizations including NIAID, CEPI, BMGF, BARDA, and the Wellcome Trust. Researchers and vaccine developers from around the world gathered to discuss the potential of mucosal vaccines in blocking SARS-CoV-2 transmission and reviewed the current research status. This summary highlights key challenges, opportunities, and recommendations to accelerate the development of mucosal vaccines for SARS-CoV-2.
Article
Multidisciplinary Sciences
Peter B. Gilbert et al.
Summary: In the COVE phase 3 clinical trial, neutralizing and binding antibodies were measured in vaccine recipients to determine their correlation with COVID-19 risk and vaccine efficacy. The results showed that these immune markers were inversely associated with COVID-19 risk and directly associated with vaccine efficacy. Postvaccination neutralization titers of 10, 100, and 1000 correlated with estimated vaccine efficacies of 78%, 91%, and 96% respectively.
Letter
Surgery
Delphine Kemlin et al.
AMERICAN JOURNAL OF TRANSPLANTATION
(2022)
Review
Immunology
Ruth I. Connor et al.
Summary: The global initiative to eradicate polio focuses on inducing mucosal immunity to limit virus replication in the intestine and restrict virus shedding through the widespread use of live and inactivated poliovirus vaccines. Recent clinical trials have shown clear differences in the ability of new combined vaccine regimens to limit virus shedding after oral challenge with live virus, with enteric neutralizing IgA playing a critical role in this process. This review summarizes key findings in vaccine-induced intestinal immunity and discusses the impact of immunization on global polio eradication efforts.
MUCOSAL IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Yongjun Sui et al.
Summary: The study shows that an intranasal booster vaccine containing the beta variant spike protein can generate protective immunity against beta variant infections, which is significant for future SARS-CoV-2 booster design and administration timing.
Article
Biochemistry & Molecular Biology
Shuo Feng et al.
Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.
Article
Medicine, Research & Experimental
Kenta Matsuda et al.
Summary: A replicating vaccine delivered to the upper respiratory tract induced potent and durable immune responses, leading to high levels of H5-specific antibodies in serum and mucosal secretions. The duration of viral shedding post-vaccination correlated with the magnitude of neutralizing antibody response at week 26.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Biochemistry & Molecular Biology
David S. Khoury et al.
Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.
Article
Medicine, Research & Experimental
Yongjun Sui et al.
Summary: Comparing two adjuvanted subunit vaccines in rhesus macaques, the study found that both vaccines were effective in protecting against respiratory SARS-CoV-2 exposure, despite potential differences in mucosal and systemic protective mechanisms. The mucosal vaccine was shown to be safe after multiple doses, efficiently clearing the input virus from the nasal cavity, and may serve as a potent complementary boost to conventional systemic vaccines for overall better protection.
